Home
About Journal
Editorial Board
Instruction
Subscribe
Download
Contact Us
Chinese
中国医学创新
2023
,
Vol. 20
Issue (11)
: 173-178
DOI
: 10.3969/j.issn.1674-4985.2023.11.041
Review
Current Issue
|
Archive
|
Adv Search
|
Recent Research on the Diagnostic and Therapeutic Value of PLA2R Antibody in Adult Patients with IMN
ZHANG Yingying, GUO Yancong
First-author's address: Graduate School Chengde Medical University, Chengde 067000, China
Abstract
Figure/Table
References
Related Citation (1)
Download:
PDF
(1513 KB)
HTML
(1 KB)
Export:
BibTeX
|
EndNote
(RIS)
Received:
24 October 2022
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
Cite this article:
URL:
http://www.zgyxcx.com/EN/10.3969/j.issn.1674-4985.2023.11.041
OR
http://www.zgyxcx.com/EN/Y2023/V20/I11/173
[1]
ZHANG Yu,LI Fuyuan,TAO Liju.
Effect and Safety of Rituximab in Patients with Non-Hodgkin's Lymphoma and Influence on Plasma Colony-stimulating Factor
[J]. 中国医学创新, 2023, 20(9): 19-22.
© 2016 中国医学创新 editorial
Address: Beijing south cellular road number five Postcodes: 100055